Receiving Radiation Therapy in the MRgRT Research Facility

Not Applicable

Recruiting

• Conditions: Solid Tumors and Metastatic Lesions

• Registration Number: NCT02701712
• Lead Sponsor: University Health Network, Toronto

Brief Summary

The aim of this study is to evaluate the technical performance of magnetic-resonance guided radiotherapy (MRgRT) facility at the Princess Margaret Cancer Centre and the impact on the workflow of the clinical team in this facility.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-02
• Study First Submitted: 2016-02-22
• Study First Submitted QC: 2016-03-02
• Study First Posted: 2016-03-08
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-12
• Last Update Posted: 2024-03-13
• Primary Completion: 2025-02
• Study Completion: 2025-02

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Ability to provide informed consent
• Planned to receive clinical intervention (imaging or treatment) in the MRgRT facility
• At least 18 years of age

Exclusion Criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Proportion of planned patients receiving treatment in the MRgRT facility	2 years

Secondary Outcome Measures

Name	Time	Method
Measure tumor size before, during and after radiotherapy	2 years	Collect and analyze imaging data before, during and after radiotherapy, and the related treatment data

Trial Locations

Locations (1)

University Health Network; 🇨🇦 Toronto, Ontario, Canada